ULTRAGENYX PHARMACEUTICAL IN (RARE)

US90400D1081 - Common Stock

56.19  +1.09 (+1.98%)

After market: 56.19 0 (0%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to RARE. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 91.6. This target is 63.01% above the current price.
RARE was analyzed by 27 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about RARE.
In the previous month the buy percentage consensus was at a similar level.
RARE was analyzed by 27 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 56.1946.4680.5891.60147.00 - -17.32% 43.41% 63.01% 161.61%
Up and Down Grades
Date Firm Action Rating
2024-10-01 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-26 RBC Capital Reiterate Outperform -> Outperform
2024-09-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-16 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-08-05 Barclays Maintains Overweight -> Overweight
2024-08-02 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-08-02 Wedbush Maintains Neutral -> Neutral
2024-08-02 Wells Fargo Maintains Overweight -> Overweight
2024-08-02 Goldman Sachs Maintains Buy -> Buy
2024-07-23 Canaccord Genuity Maintains Buy -> Buy
2024-07-22 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-07-18 Wedbush Reiterate Neutral -> Neutral
2024-06-12 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-06-06 Goldman Sachs Upgrade Neutral -> Buy
2024-05-31 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-05-31 Stifel Maintains Buy -> Buy
2024-05-31 Wedbush Maintains Neutral -> Neutral
2024-05-31 Baird Maintains Outperform -> Outperform
2024-05-31 Canaccord Genuity Maintains Buy -> Buy
2024-05-31 B of A Securities Maintains Buy -> Buy
2024-05-06 Canaccord Genuity Maintains Buy -> Buy
2024-05-03 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-05-03 Wedbush Maintains Neutral -> Neutral
2024-04-24 TD Cowen Maintains Buy -> Buy
2024-04-22 RBC Capital Initiate Outperform
2024-04-17 Wedbush Reiterate Neutral -> Neutral
2024-04-16 Wedbush Reiterate Neutral -> Neutral
2024-04-05 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-03-18 JP Morgan Maintains Overweight -> Overweight
2024-02-27 Cantor Fitzgerald Maintains Overweight -> Overweight